OL
BIO icon

one8zero8 LLC’s Bio-Rad Laboratories Class A BIO Stock Holding History

one8zero8 LLC’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-674
Closed -$204K – 262
2025
Q4 		$204K Buy
+674
New +$210K 0.04% 206
2025
Q1 		– Sell
-674
Closed -$221K – 260
2024
Q4 		$221K Buy
+674
New +$229K 0.05% 206

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

one8zero8 LLC's BIO Position: Q1 2026 in Review

one8zero8 LLC sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2026, closing a stake of 674 shares — an estimated $204K sold.

one8zero8 LLC first reported a position in BIO in Q4 2024 and held it in 2 quarters. The position peaked at $221K in Q4 2024. 394 funds tracked by Wall St. Rank hold BIO as of Q1 2026.

  • one8zero8 LLC reported no remaining Bio-Rad Laboratories Class A position as of Q1 2026 after selling out during the quarter.
  • one8zero8 LLC sold 674 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $204K.
  • one8zero8 LLC first reported a position in Bio-Rad Laboratories Class A in Q4 2024 and held it in 2 quarters.
  • one8zero8 LLC's Bio-Rad Laboratories Class A position peaked at $221K in Q4 2024.
  • 394 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.

Based on one8zero8 LLC's 13F filing for Q1 2026, filed 7 May 2026.